Stock Events

Stock Events

MagForce 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-2,878.08%Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
543,000Revenue
-15.63MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical produces robotic surgical systems, often used in oncologic surgeries, competing in the broader field of advanced medical treatments for cancer.
Medtronic
MDT
Mkt Cap123.49B
Medtronic offers a range of medical technologies, including neurosurgical products, which compete with MagForce's neuro-focused cancer treatments.
Boston Scientific
BSX
Mkt Cap61.74B
Boston Scientific produces medical devices that are used in various interventions including cancer treatments, positioning them as a competitor in the oncology device market.
Stryker
SYK
Mkt Cap105.65B
Stryker Corporation manufactures and markets medical devices, including surgical equipment and neurotechnology products that compete with MagForce's offerings.
Globus Medical
GMED
Mkt Cap10.15B
Globus Medical specializes in spine and neurosurgery products, competing with MagForce in the neuro-oncological device sector.
Zimmer Biomet
ZBH
Mkt Cap16.84B
Zimmer Biomet Holdings, Inc. provides various medical devices and solutions that can be used in surgical settings, including those for cancer, competing indirectly with MagForce.
Edwards Lifesciences
EW
Mkt Cap49.08B
Edwards Lifesciences specializes in heart and vascular health technologies, which indirectly competes with MagForce's cancer treatment technologies in the broader medical device market.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers a wide range of healthcare solutions including medical devices, some of which are used in cancer treatments, making them a competitor.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in multiple healthcare sectors, including the production of medical devices for cancer treatment, competing across many of MagForce's markets.

About

MagForce AG operates in the field of nanotechnology-based cancer therapy in Germany and Poland. It offers NanoTherm, a therapy for the treatment of solid tumors; NanoPlan, a simulation software that helps the treating physicians to define the NanoTherm therapy schedule according to the distribution of the NanoTherm depots in the tumor; and NanoActivator, a magnetic field applicator. MagForce AG was founded in 1997 and is headquartered in Berlin, Germany.
Show More
CEO
Dr. Benjamin J. Lipps
Employees
34
Country
Germany
ISIN
DE000A0HGQF5
WKN
000A0HGQF

Listings

MU
DE
MF6.MU
STU
DE
MF6.STU
LSE
GB
0W10.LSE

0 Comments

Share your thoughts

FAQs

What is MagForce stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange MagForce stocks are traded under the ticker MF6.MU.
What is MagForce revenue for the last year?▼
MagForce revenue for the last year amounts to 543,000 EUR.
What is MagForce net income for the last year?▼
MF6.MU net income for the last year is -15.63M EUR.
How many employees does MagForce have?▼
As of November 2, 2026, the company has 34 employees.
In which sector is MagForce located?▼
MagForce operates in the Energy sector.
When did MagForce complete a stock split?▼
MagForce has not had any recent stock splits.
Where is MagForce headquartered?▼
MagForce is headquartered in Berlin, Germany.